An induced pluripotent stem cell line (MUSIi019-A) generated from a patient with distal renal tubular acidosis carrying a compound heterozygous mutation in solute carrier family 4 member 1 (SLC4A1) gene

被引：0

作者：

Kaewboonlert, Narissara ^{[1
,2
]}

Wattanapanitch, Methichit ^{[3
]}

Praditsap, Oranud ^{[4
]}

Deejai, Nipaporn ^{[1
]}

Chanprasert, Chutima ^{[5
]}

Sawasdee, Nunghathai ^{[1
]}

Nettuwakul, Choochai ^{[1
]}

Wanachiwanawin, Wanchai ^{[6
]}

Sritippayawan, Suchai ^{[7
]}

Thamtarana, Prapaporn Jungtrakoon ^{[5
]}

Yenchitsomanus, Pa-thai ^{[1
]}

Rungroj, Nanyawan ^{[4
]}

机构：

[1] Mahidol Univ, Fac Med, Siriraj Hosp, Div Mol Med,Res Dept, Bangkok, Thailand

[2] Mahidol Univ, Fac Med, Siriraj Hosp, Biomed Sci Program, Bangkok, Thailand

[3] Mahidol Univ, Siriraj Ctr Regenerat Med, Res Dept, Fac Med,Siriraj Hosp, Bangkok, Thailand

[4] Mahidol Univ, Fac Med, Siriraj Hosp, Siriraj Genom, Bangkok, Thailand

[5] Mahidol Univ, Cellular & Mol Biol Diabet Res Grp, Siriraj Hosp, Div Mol Med,Res Dept,Fac Med, Bangkok, Thailand

[6] Mahidol Univ, Fac Med, Siriraj Hosp, Div Hematol,Dept Med, Bangkok, Thailand

[7] Mahidol Univ, Fac Med, Siriraj Hosp, Div Nephrol,Dept Med, Bangkok, Thailand

来源：

STEM CELL RESEARCH | 2023年 / 67卷

关键词：

Distal renal tubular acidosis; Hemolytic anemia; iPSC; SAO;

D O I：

10.1016/j.scr.2023.103043

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Distal renal tubular acidosis (dRTA), a disease characterized by the failure of the distal nephron to secrete acid into the urine, can be caused by mutations in SLC4A1 gene encoding erythroid and kidney anion exchanger 1 (AE1). Here, an induced pluripotent stem cell (iPSC) line was generated from a patient with dRTA and hemolytic anemia carrying compound heterozygous SLC4A1 mutations containing c.1199_1225del (p.Ala400_Ala408del), resulting in Southeast Asian ovalocytosis (SAO), and c.1331C>A (p.Thr444Asn). Peripheral blood mononuclear cells (PBMCs) were reprogrammed using Sendai viral reprogramming. The established iPSC line, MUSIi019-A, exhibited pluripotent property and retained the same mutations observed in the patients.

引用

页数：5

共 50 条

[21] Establishment of the induced pluripotent stem cell line (NCKDi005-A) from a male patient with Alport syndrome carrying a homozygous frameshift mutation in the COL4A4 gene
Wang, Gang
Gao, Erzhi
Wu, Hangdi
Zhang, Li
Zhu, Yuqing
Zhang, Jin
Liu, Zhihong
STEM CELL RESEARCH, 2022, 58
[22] Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene
Wang, Xianming
Chen, Shen
Burtscher, Ingo
Sterr, Michael
Hieronimus, Anja
Machicao, Fausto
Staiger, Harald
Haering, Hans-Ulrich
Lederer, Gabriele
Meitinger, Thomas
Lickert, Heiko
STEM CELL RESEARCH, 2016, 17 (02) : 292 - 295
[23] Generation of an induced pluripotent stem cell line (ZSPHARi002-A) from a patient with autosomal dominant polycystic kidney disease carrying a heterozygous PKD1 mutation
Zhang, Yeye
Chen, Ye
Fan, Jun
Lu, Guangzhao
Lv, Qianzhou
Lao, Donghui
Li, Xiaoyu
STEM CELL RESEARCH, 2025, 82
[24] Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene
Wang, Xianming
Chen, Shen
Burtscher, Ingo
Sterr, Michael
Hieronimus, Anja
Machicao, Fausto
Staiger, Harald
Haering, Hans-Ulrich
Lederer, Gabriele
Meitinger, Thomas
Lickert, Heiko
STEM CELL RESEARCH, 2016, 17 (02) : 273 - 276
[25] Generation of a human induced pluripotent stem cell line (SBWCHi001-A) from a patient with NEDSDV carrying a pathogenic mutation in CTNNB1 gene
Yan, Rui
Liu, Pengyu
Li, Fake
Chu, Meng
Lei, Jiafan
Wang, Feng
Luo, Liangping
Xu, Xueqing
STEM CELL RESEARCH, 2020, 49
[26] Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation
Wang, Yanlin
Jing, Na
Su, Linlin
Shi, Changhe
Zhang, Pei
Wang, Zhilei
Sun, Huifang
Yang, Jing
Liu, Yutao
Wen, Xuejun
Zhang, Jin
Zhang, Shoutao
Xu, Yuming
STEM CELL RESEARCH, 2018, 27 : 30 - 33
[27] Generation of an induced pluripotent stem cell line (CSBZZUi001-A) from a female Alzheimer's patient carrying the PSEN1 709 T > C heterozygous mutation
Meng, Xiao-Yan
Sun, Hui-Fang
Zhang, Ying-Jie
Li, Wen-Xiu
Wang, Dian -Dian
Liu, Dan-Hua
Li, Sen-Miao
Wu, Yue
Li, Jia-Kang
Liu, Xiao-Hui
Liu, Pei -Pei
Yang, Run-Zhou
Li, Shu-Ang
Kang, Jian-Sheng
STEM CELL RESEARCH, 2024, 79
[28] Generation of the induced pluripotent stem cell line (NCKDi002-A) from a 22-year-old patient with Focal Segmental Glomerular Sclerosis carrying a heterozygous mutation in WT1 gene
Wu, Hangdi
Wang, Gang
Gao, Erzhi
Zhao, Jing
Zhang, Li
Chen, Lang
Zhu, Yuqing
Zhang, Jin
Liu, Zhihong
STEM CELL RESEARCH, 2021, 53
[29] Generation of a human induced pluripotent stem cell (iPSC) line from skin fibroblasts of a patient carrying an E363Q mutation in PSEN1 gene
Zhu, Wanwan
Zhou, You
Wang, Qingyu
Li, Jie
Chu, Shanshan
Jin, Wei
Mao, Chenhui
Dong, Liling
Gao, Jing
Xu, Qi
STEM CELL RESEARCH, 2022, 61
[30] Generation of an induced pluripotent stem cell line XJHi001-A from a fibronectin glomerulopathy patient carrying a heterozygous NM_212482.2 (C.5888-1G> C) mutation in the FN1 gene
She, Lecheng
Li, Xiayin
Bai, Ming
STEM CELL RESEARCH, 2023, 72

← 1 2 3 4 5 →